This document may not be reprinted without the express written permission of Arkansas Democrat-Gazette Material from the Associated Press is Copyright © 2025 audio and/or video material shall not be published rewritten for broadcast or publication or redistributed directly or indirectly in any medium Neither these AP materials nor any portion thereof may be stored in a computer except for personal and noncommercial use The AP will not be held liable for any delays errors or omissions therefrom or in the transmission or delivery of all or any part thereof or for any damages arising from any of the foregoing Financier Worldwide has been providing valuable information on corporate finance and board-level business issues through its monthly print magazine and exclusive website content. As a leading publisher of news and analysis on this dynamic global market the organisation is immediately recognisable as a valued source of intelligence to the corporate Please take a moment to join our free e-mailing list to receive notifications about the latest content JOIN MAILING LIST Corporate Disputes Risk & Compliance Follow Us November 2023  |  SPECIAL REPORT: HEALTHCARE & LIFE SCIENCES SECTOR FW discusses life sciences M&A with Sonia de Kondserovsky Victoria Rhodes and Mathias Schulze Steinen at DLA Piper FW: How would you describe the current appetite of companies in the life sciences sector for dealmaking To what extent can M&A assist companies looking to bolster product pipelines improve efficiencies and tap into new markets Gilbert: Dealmaking remains a core component of most life sciences companies’ business models biotechnology companies’ goals are to license or sell their assets or company to large pharma at an appropriate stage of development and pharma companies are constantly looking to enhance their pipelines of new therapeutics or enter new markets The current market has not altered those objectives there are significant factors that have impacted the volume of transactions Higher interest rates and regulatory and legislative developments in the US have created a pause in the M&A market The larger acquisitive companies are still digesting assets acquired over the last few years and are less likely to part with cash in this environment for less than ideal targets depressed market caps for many biotechnology companies even those with positive clinical data and a regulatory approval pathway European and Asian companies remain very interested in acquiring US companies or licensing US assets to establish commercial capabilities in the US market Li: The lack of liquidity in the domestic China life sciences market is palpable While the US to date does not explicitly restrict US investment in Chinese life sciences companies – unlike Chinese artificial intelligence (AI) quantum computing and advanced semiconductor companies where US investment is now heavily restricted – US funds and US dollar limited partners have dramatically curtailed their investment allocations to China owing to a host of reasons China’s own institutional investors are still absorbing and digesting the market downturn and weighing their next moves – while large amounts of state and non-state funding continue to pour into infrastructure and semiconductor sectors Multinational corporations (MNCs) – and US MNCs in particular – will see some of their Chinese start-up competitors wobble Chinese public companies in the life sciences space remain cash rich to attempt cross-border acquisitions to improve their product and intellectual property (IP) portfolios Many of them will become increasingly interested in setting up research and development (R&D) platforms in the US and in other developed markets; to that end they are keenly aware of the regulatory and trade barriers The good news is the Committee on Foreign Investment in the United States (CFIUS) has approved a number of Chinese investments in and acquisitions of US life sciences companies even while US-China competition remains intense Steinen: The appetite of companies is still big and there is lots of M&A activity in the European life sciences sector Market players constantly want to improve their portfolio efficiency to adapt regulatory changes or the latest technical developments such as AI big M&A tickets dropped slightly due to higher interest rates in the market the transactional approach has changed as market players have become more risk averse This has resulted in a rise in partnerships and other forms of collaborations FW: To what extent are regulatory changes or pressures influencing M&A strategies de Kondserovsky: The life sciences sector is increasingly regulated in the European Union (EU) – at both local and EU levels Such regulatory changes have not undermined the appetite for M&A transactions in the sector but have created numerous complexities which impact deal process deadlines recent legislative changes have included investment in biotechnologies within the scope of the foreign investment regulations requiring the prior authorisation of the Ministry of Finance Although there are no known precedents of refusals the ministry has sometimes conditioned its approval to commitments taken by the foreign purchaser such as maintaining manufacturing facilities in France Another example is the European Medical Device Regulation (EU MDR) which introduced major changes regarding pre-market conformity requirements its implementation has turned out to be very challenging for companies The European Commission (EC) has thus reacted to companies’ concerns by delaying the EU MDR implementation by four years CFIUS and anti-merger sentiment within the US administration has presented challenges for dealmaking for larger deals have not had a significant impact in the middle market and acquisitive companies can acquire assets or companies without meaningful concerns of US governmental intervention may likely take longer as the deals are reviewed for competitive issues FW: Have any recent life sciences deals caught your eye What market insights can we draw from these deals Steinen: Some large transactions in the first half of 2023 including the acquisitions of Prometheus Biosciences by Merck and of Seagen by Pfizer indicate that big pharma might try to compensate the expiration of ‘blockbuster’ patents by major buy-ins Another noticeable trend can be seen in the acquisition of orphan drugs that have increasingly become the target of M&A activities The acquisition of Chinook Therapeutics by Novartis is a prominent example Due to high profit margin in a market with less competition the market for treatment of rare diseases sees higher growth rates Recent M&A activities in life sciences tend to focus on genetic medicine The acquisition of Polyplus by Satorius is a good example here It is also worth noting in this context that the three largest financing rounds in the biotechnology sector in the US were secured by companies that are all involved in gene and cell therapy Rhodes: The £4.46bn EQT takeover of Dechra – which is still awaiting various regulatory approvals – is a great success story for an innovative company in the veterinary space achieving a multiple of 25.9 percent earnings before interest depreciation and amortisation (EBITDA) and a premium of around 44 percent on its share price While it will be a blow to the London markets for it to delist and reflects current market conditions in the capital markets it is an exciting development for the company and shows that there are deals to be done for high quality companies FW: What advice can you offer to companies in terms of scoping deals and identifying opportunities across the life sciences sector Li: In the many markets with a general shortage of liquidity in the current high interest rate climate including China and many of the more developed markets start-up companies may be starving for funding Many large local institutional investors that ordinarily fund later stage start-ups are now looking to invest in earlier stage start-ups; this is driving up the valuation of earlier stage start-ups while leaving behind a bigger vacuum for later stage financing or exits While this phenomenon operates to depress the market strategic or private equity (PE) investors that do have access to cash can leverage the phenomenon to find opportunities – especially cross-border opportunities such as Middle East investors investing in China or Chinese investors investing in developed markets – to invest in or acquire synergistic start-up businesses or technologies at a bargain price Gilbert: Buyers in markets with a general shortage of liquidity have a distinct advantage in many cases due to the lack of or reduction in bid competition for many assets compared to prior years As capital markets have been largely shut for biotechnology companies and venture capital has become much more selective many such targets are cash poor and need to transact in order to advance the lead programmes and extract value for their stakeholders Potential buyers are scrutinising assets at a much higher level than in prior years Potential sellers need to plan for longer and tougher due diligence processes Understanding the realities and dynamics of the current market and each party’s resulting leverage or lack thereof is an important aspect of transacting more than ever Rhodes: Current market conditions are fostering a more buyer-friendly environment than we have seen in recent years The price of debt is also swaying in favour of corporate buyers who can sometimes take slightly longer to transact but can have an advantage in not having to leverage the transaction Considering the regulatory position at the very start of the deal is now critical especially in the life sciences sector as we see increased antitrust and regulatory regimes across jurisdictions impacting on deals in this sector FW: To what extent have you seen foreign direct investment regulations impacting on deal terms and timetables Do you anticipate a similar picture in the next 12-18 months Gilbert: The life sciences industry generally has long embraced a global approach and utilised foreign direct investment (FDI) to facilitate R&D and to enter new markets Companies and funds investing internationally generally looked to jurisdictions that had demonstrated robust R&D capabilities as well as a regulatory environment that was receptive to investment and novel therapeutics and vaccines The recent developments in FDI regulation in virtually all countries and regions has only had a modest impact on investment activity to date but we expect to see more scrutiny of more transactions as regulators continue to expand the scope of technologies covered by the regimes transactions which require mandatory filings and agency review will take longer this may limit the deployment of needed international capital into the sector and reduce competition for transactions Li: China has for some years adopted a ‘negative list’ approach to foreign market access While China’s bureaucracy is known to be burdensome on administration where the proposed market access does not – as is the case for most life sciences projects – fall into an industry on the negative list it now takes minimal government approval to complete a transaction China does have a national security review regime for inbound M&A transactions but the regime has been invoked on very few occasions – given that foreign market access is already subject to plenty of government scrutiny in any event – so few that there are hardly any reported cases and most foreign investors see FDI review as a much lesser risk than that related to China’s merger control clearance Steinen: There has recently been an increase in the application of FDI regulations in various European countries The life sciences sector is also affected and receives more attention from lawmakers and regulators such as when the companies involved are active in the development of mass products such as vaccines and antibiotics The wider application of FDI regulation has an impact on deal terms such as the allocation of risks related to the outcome of the approval process or the time until completion of a transaction how important is it for life sciences companies to undertake thorough due diligence alongside other steps to manage transactional risk Rhodes: The Theranos case has highlighted the importance of undergoing appropriate due diligence in life sciences transactions While diligence is important in all M&A transactions for life sciences companies the additional regulatory regimes which can apply alongside the need to examine valuable IP rights and the potential for sensitive personal data to be processed means that there are some areas of diligence which may be fundamental depending on the asset or business being acquired The potential for risks which arise in a life sciences transaction to be significant if not identified means that early and strategic consideration of the diligence scope is critical to ensuring that the greatest focus is on the real value items and risk areas This also helps to ensure that diligence which adds value to the M&A process is undertaken on an economic basis tend to hold themselves to higher operational standards in China and Chinese regulators tend to scrutinise them on the basis of such higher standards anti-commercial-bribery – especially in light of China’s crackdown on corruption in public hospitals this past summer – anti-financial fraud data privacy or in relation to other operational aspects These investors would be well advised to conduct thorough diligence on their M&A targets and sign the acquisition agreement with their eyes open FW: How important is it for companies in this sector to pay careful attention to intellectual property and related licences when drafting transaction documents de Kondserovsky: IP rights are often the key assets of any M&A transaction in the life sciences sector thorough due diligence and specific representations and warranties that IP rights are properly transferred and protected is critical The scope of the due diligence and warranties should include ownership valid registration and the absence of infringements or encumbrances For biotechnology transactions in particular special attention should be paid to third-party licences existing or needed to protect the business Li: While China lags behind the US in its portfolio of foundational technologies in life sciences it remains one of the world’s largest markets to commercialise new technologies Allocation of IP rights among key market participants and stakeholders is no less critical in China transactions than in US transactions FW: What general steps should companies take in the pre- and post-deal phases to help deliver the intended benefits of a transaction and optimise long-term value Rhodes: It is critical that all internal stakeholders are aligned on what the strategic value of a transaction is and that this is communicated to all the advisory team This can impact on how diligence is approached the appetite for risk in certain areas and the drafting of the transaction documents Failure to communicate where the value lies could lead to a suboptimal process and failure to realise the value which is sought It is equally critical to ensure that this messaging is passed to the post-deal integration team It is still the case that integration is often left to those not involved in the deal and then the value which was hoped to be achieved may be missed during the transaction as issues arise and terms are negotiated gives the best chance of realising value from the transaction de Kondserovsky: Special attention to retention of key employees should be sought through an adequate compensation package and the proper definition of such employees’ position and status specific attention should be paid to employees possessing the know-how in companies where R&D or manufacturing is key FW: How do you envisage M&A in the life sciences sector developing over the coming months M&A deal volume will largely be driven by developments in capital markets If the initial public offering (IPO) market for later stage biotechnology companies does not rebound those venture capital-backed companies with promising pipelines will need to pursue an acquisition to continue to advance their programmes We are starting to see signs of life in the IPO market with a few deals but it is too early to determine whether it will be sustained many of the smaller publicly traded biotechnology companies have market cap challenges making follow-on offerings more challenging and as a result such companies will also become likely targets despite the multitude of potential targets many strategic pharmaceutical companies are likely to remain relatively inactive due to pressures in their core commercial businesses and need for cash preservation We would expect the larger pharmaceutical companies to be more focused on commercial targets rather than development stage companies PE firms with sufficient capital to acquire targets and fund the ongoing business without utilising debt which has become more expensive and less available Rhodes: We expect that large pharmaceutical companies will try to offset declining revenues due to patent expirations by acquiring innovative later stage biotechnology companies The increasing need for AI that can help to reduce cost and time to develop drugs or medical products also looks likely to result in an increase of M&A activities as many life sciences companies are likely to choose to buy-in and integrate the relevant technological expertise and products from the outside rather than developing these organically de Kondserovsky: Due to increased interest rates PE funds will have more difficulty raising capital and asset valuations should thus ultimately decrease This will provide opportunities for cash-rich industrial groups to acquire a variety of biotech and medical technology companies Steinen: I envisage not so much of a development as a continuation I anticipate seeing even more AI-focused deals in the life sciences sector by both medical device and biotech companies and also in the pharmaceutical sector Given the recent interest in the sector from the EC and the Federal Trade Commission (FTC) it seems likely that caution may be applied to some of the larger transactions but we will still continue to see deals where they are of strategic value and importance Li: China outbound M&A in life sciences will continue The US and the EU will be prime destinations Middle Eastern investors will potentially fill the void left by US investors for funding Chinese life sciences start-ups which will continue to seek IPOs in the US or in Hong Kong Sonia de Kondserovsky heads the Paris life sciences practice and advises pharmaceutical and medical device companies on national and cross-border acquisitions and divestments distribution agreements and regulatory matters related to M&A transactions She can be contacted on 33 1 4015 6693 or by email: sonia.dekondserovsky@dlapiper.com Andrew Gilbert specialises in corporate finance mergers and acquisitions and securities law technology and investment firms serving these sectors underwriters and venture capital firms in public and private offerings He can be contacted on +1 (973) 520 2553 or by email: andrew.gilbert@dlapiper.com Qiang Li has practiced law in Hong Kong and Shanghai since 1997 He guides multinational and Chinese clients on cross-border M&A and investments in the life sciences sector He also advises on China’s foreign investment laws has served as counsel to the board for the American Chamber of Commerce in Shanghai and is a recognised authority on legal reforms in market access corporate finance and governance. He can be contacted on +86 21 3852 2168 or by email: qiang.li@dlapiper.com Victoria Rhodes is an accomplished corporate finance lawyer specialising in domestic and cross-border M&A joint ventures and international reorganisations She is recognised as an Acritas Legal Star She can be contacted on +44 (0)113 369 2044 or by email: victoria.rhodes@dlapiper.com Dr Mathias Schulze Steinen boasts 20-plus years advising strategic and financial investors on domestic and cross-border deals corporate finance and restructuring in the life sciences sector and unwavering support throughout transactions He can be contacted on +49 69 2713 3430 or by email: mathias.schulze.steinen@dlapiper.com  Sonia de Kondserovsky Andrew Gilbert Qiang Li Victoria Rhodes Mathias Schulze Steinen Healthcare & life sciences sector Q&A: Data analytics in life sciences Strategic considerations in life sciences partnering Cost-effective management of IP for life science companies Knee-jerk reaction to COVID-19 – lean times ahead for some Evaluating effort EU regulation of artificial intelligence in healthcare Q&A: Life sciences M&A BLOOMINGTON — Many colleges and universities in Central Indiana are gearing up for the first day of fall semester next week thousands of incoming freshmen began the move-in process earlier this week Just a fun time," 18-year-old Tom Von Den Steinen said Von Den Steinen is a first year student at IU He’s studying business and says he’s excited to attend his first IU basketball game this year And he’s happy it’s only a four and a half hour drive back home to Chicago Wisconsin-native Audrey Davies is studying finance I’m living in my mom’s dorm which is Teter Their biggest advice as she steps foot on campus for the first time “They told me to go to all my classes and to have fun," Davies said Freshman Elaina Cook is studying business and says she’s excited to explore campus “I really love all the green spaces and I love the architecture Everything matches so well it’s very pretty," Cook said Davies and Cook are three of the estimated 9,500 incoming freshman at the university’s Bloomington campus this year “The whole environment in Bloomington shifts getting excited to actually seeing it happen and that is this moment getting ready for classes," Senior Associate Dean of Students Libby Spotts said It’s a chance for students to explore the campus connect to resources and learn everything there is to know about being a Hoosier It includes the New Student Induction Ceremony “We’re helping students navigate this huge place We’re helping them figure out where their classes are We’re helping them meet each other and really feel welcomed as Hoosiers here at IU Bloomington," Spotts said Meghan Vonden Steinen and Gary Bonomo G’10 enjoy liquid-nitrogen ice cream High school students interested in the emerging field of sustainability chemistry recently converged at Syracuse University for the first annual Green Chemistry Think Tank Co-sponsored by the Central New York Section of the American Chemical Society (CNY ACS) and the Manlius Pebble Hill (MPH) School, the event took place in the Life Sciences Complex and involved members of the Department of Chemistry in the College of Arts and Sciences (A&S) Gillett-Kunnath G’08—an A&S staffer and researcher respectively—co-organized the Think Tank with Sue Foster chemical processes and commercial products that do not generate toxins or waste “Green chemistry enables us to create Earth-friendly alternatives to hazardous substances,” explains Bonomo “The Think Tank featured demonstrations on recycling Students also made their own sugar scrubs and enjoyed liquid-nitrogen ice cream.” Sue Foster chairs the science department at the Manlius Pebble Hill School The evening program drew more than 60 students from eight area high schools Foster suspects that because the event was not admissions-driven participants enjoyed science for the sake of it “High school students have minimal opportunity to network with peers from other schools Feeling the energy of the SU campus and spending the evening talking about science—it’s a win-win for everyone,” she adds The program included opening remarks by A&S Dean Karin Ruhlandt also a Distinguished Professor of Chemistry and a “sustainability spin wheel,” with which students competed for prizes from A&S the chemistry department and the Science Teachers Association of New York State (STANYS) devised and operated the spin wheel with students from the Institute of Technology at Syracuse Central where he is a New York State Master Teacher was a star with the liquid-nitrogen ice cream,” says Gillett-Kunnath A research assistant professor in Ruhlandt’s lab Gillett-Kunnath also is a technical specialist in Barclay Damon’s Intellectual Property Litigation practice area Rubenstein Museum of Science & Technology (MOST) and a recent recipient of the STANYS Excellence in Teaching Award She and Bonomo credit Foster for getting the word out to high school and county officials of the Onondaga County Resource Recovery Agency (OCCRA) and “Save the Rain”—the county’s comprehensive storm-water management plan benefiting Onondaga Lake and its tributaries—at the event The Think Tank also featured remarks by local scientists Other presenters hailed from the Syracuse City School District MPH’s “Green Avengers” environmental club and the Auburn Enlarged School District “Students came from all over Central New York Prin Furst [also a New York State Master Teacher] a lab supervisor and general chemistry lab instructor in A&S “A lot of people banded together to make the day an enrichening experience.” Chemistry majors Ashley Clements and Meghan Vonden Steinen helped Bonomo serve up fresh Foster recalls one attendee who turned up alone and unannounced admitting she had forgotten to register for the Think Tank and that no one from her school offered to accompany her “The evening turned out to be pivotal for her.” On a wave-battered rock in the Northern Pacific Ocean a fish called the sculpin grips the surface firmly to maintain stability in its harsh environment which use their glue-secreting tube feet to adhere to their surroundings Varshney has exemplified Orange excellence since joining the University as a 23-year-old faculty member he’s been recognized for his seminal contributions to information fusion and related fields Peter Wirth has a two-fold strategy when it comes to renovating his home native has called Central New York home for more than 40 years Nestled on a quiet cul-de-sac in Fayetteville While many of her peers were enjoying the time off between high school graduation and starting college Luiza Owuor ’26 was participating in the University’s Career Acceleration via Rigorous Educational Experiences in Research (CAREER) program After completing an “Intro to Artificial Intelligence (AI)” course in the College of Engineering and Computer Science (ECS) Emma Bellai ’25 was eager to apply everything she learned in class to her internship with Verizon If you need help with your subscription, contact sunews@syr.edu Norske og internasjonale forskningsnyheter “The earliest evidence of falconry that we have is the Gokstad ship from around the year 900 The ship was used as a grave chamber and two northern goshawks were found among the grave goods the elite were clearly the ones hunting with falcons,” says Ragnar Lie Lie works as a cultural heritage consultant in Vestfold and Telemark counties In 2021, the Norwegian Institute for Cultural Heritage Research discovered a figure depicting a royal falconer during excavations in the Medival park of Oslo The object probably originated no later than 1250 Birds of prey were used to hunt both small game and other birds Although the earliest traces of falconry are from the year 900 “Falconry probably started a little earlier,” says Lie In Sweden you can find traces back to the 5th century “There’s no reason to believe that falconry didn't then also penetrate Norwegian aristocratic circles” The phenomenon probably came to Europe in the 1st century CE and the Eurasian steppe landscape is considered the area of falconry’s origin,” Lie says The practice might have occurred independently in different parts of the world That hunting with falcons was an activity for the elites has been oft repeated in books and scientific articles published on the subject The article ‘Norge og de britiske øer i middelalderen’ (Norway and the British Isles in the Middle Ages) written by historian Alexander Bugge in 1914 Norwegian and Icelandic falcons played no small role Bugge writes about so-called missions to England from the 12th to the 14th century “Most Norwegian missions had no other purpose than to bring gifts the Norwegian kings sent hawks and goshawks as gifts,” writes Bugge The gifts were to be given the royals on the other side of the North Sea who was king of Norway between 1217 and 1263 sent falconers to Iceland to capture white Icelandic falcons These are said to have been valued more highly than silver and gold by the English royal family Lie has also written about hawks and falcons as export goods Gyrfalcons were the most sought-after export item since they were only found in northern areas and did not migrate south The goshawk’s status was somewhat lower than that of the falcon But it was in many ways more convenient to use the goshawk is also a skilled hunter in the forest or in cultural landscapes This contributed to the goshawk likely being a major export item especially to England through the Middle Ages But couldn’t people in lower social classes also have used birds of prey as a tool in hunting “The evidence we have shows falconry happening among the elite Sweden has now discovered 40 different tombs containing birds of prey from the Iron Age” So we can’t rule out that they might have done falconry but the activity seems to belong to the aristocratic set it could be that birds and humans collaborated for a while in connection with supplementing the food supply.” Hunting with falcons on a large scale must also have been very resource intensive “You can have a goshawk and hunt for yourself but as soon as you build an apparatus around it the costs quickly rise to a level that few could maintain,” Lie states Falconry indeed became expensive when kings and noblemen went hunting you needed to have a hunting ground – and last but not least people were starving while the king pursued hunting and falconry A light went on for people that such an outrageous use of resources wasn’t politically correct,” Lie says the king was no longer to lead troops into battle And the king who trained for hunting and achieved social status through hunting Falconry became much less visible in society the aristocratic use of birds of prey declined dramatically The church believed it was both a waste and a vanity Ragnar Orten Lie and Frans-Arne Stylegar write about this in an article in the magazine Primitive Tider (Primitive times) in 2021 The nobility came back with no shortage of counter-arguments They argued that hunting was training for war – and that training for war was a duty this type of hunting achieved a slightly different status Falconry becomes a more sophisticated form of hunting that requires more knowledge Many birds of prey were persecuted and hunted throughout the 19th century and parts of the 20th century the Norwegian organisation Birdlife writes on its website Several species were on the verge of extinction in the mid-20th century Lie believes falconry’s fluctuating status through the ages shows an exciting development birds of prey went on to be considered a nuisance Birds of prey were lumped together as being in competition with humans for the prey a war of extermination was started against birds of prey Eggshells became fragile and broke during incubation The result was that few young made it to adulthood several species of birds of prey were protected there’s absolutely no question of falconry in Norway anymore,” says Lie The population of many species has increased in recent decades “What’s fun about working with the phenomenon is that it has great cultural-historical relevance,” says Lie He finds it especially exciting because many are not aware of how widespread falconry was in Norway during the Middle Ages There are also important environmental issues associated with hunting with these birds especially since the tradition is on its way back in some countries In countries like the United Arab Emirates, gyrfalcons are even required to obtain their own passports. This came in handy when a Saudi prince booked airline tickets for his 80 falcons. Aftenposten wrote about this in 2017 (link in Norwegian) The tradition of falconry can put pressure on the population of the birds of prey that are used The female birds are slightly larger than the males and the cooperation between the environmental side and falconers is positive Lie, Ragnar Orten and Stylegar, Frans-Arne Hedlund: Veidekongen, olifanten og bøkeskogen (The Hunter king, the olifant and the beech forest): Hunting, war and aristocratic ideology in the Viking Age and the Middle Ages. Primitive tider, 2021. (Summary) Read the Norwegian version of this article at forskning.no Sciencenorway.no brings you science news from Norway.This is the English version of forskning.no online newspaper on science.Sciencenorway.no har artikler fra forskning.no på engelsk Privacy policy Sciencenorway.no follows the Norwegian Editor’s Code and the Code of Ethics of the Norwegian Press Editor-in-chief / publisher: Aksel Kjær Vidnes+47 922 47 741 / aksel@forskning.noAssistant editor: Alette Bjordal Gjellesvikalette@forskning.no Researcher's Zone: Frithjof Eide Fjeldstad frithjof@forskning.no Ads and market: Preben Forberg+47 413 10 879 / preben@forskning.noAddress: Sandakerveien 24 C / D3 One of the latest models in the Porsche 911 family will soon be available as a Lego Technic replica The construction set of the sports car made from 2704 building elements which was developed in collaboration with Porsche AG Like every sports car with the Porsche crest on the hood the Lego version of the Porsche 911 GT3 RS combines design Disguised as a prototype in black and white foil at the toy fair in Nuremberg the color of the characteristic body has now been unveiled and shines in bright orange It is thus authentically modeled on the special lava orange paintwork of the sports car There is also a comprehensive collector's book with background information on the development of the model The Lego Technic Porsche 911 GT3 RS is designed on a scale of 1:10 57 centimeters long and 25 centimeters wide store.lego.com Photo: Factory Please enable JS and disable any ad blocker This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page Aber keine Sorge: Sie sind nicht der Erste Schon viele Leute in unserer Region haben Dinge verloren – und häufig auch wiedergefunden Zur Finanzierung unseres journalistischen Angebots spielen wir Ihnen Inhalte und personalisierte Werbung mit Tracking aus, die von Drittanbietern kommen In der Datenschutzerklärung und den Privatsphäre-Einstellungen finden Sie weitere Details Ihre Zustimmung ist jederzeit über den Link „Privatsphäre“ am Ende jeder Seite widerrufbar Nutzen Sie unser Angebot ohne Werbetracking durch Dritte für 4,99 EUR/Monat (rabattiert für SÜDKURIER-Abonnenten auf 1,99 EUR/Monat) Tracking durch Dritte: Zur Finanzierung unseres journalistischen Angebots spielen wir Ihnen Werbung aus Zu diesem Zwecke setzen diese Dienste Tracking-Technologien ein Hierbei werden auf Ihrem Gerät Cookies gespeichert und ausgelesen oder Informationen wie Geräte-Kennung abgerufen um Anzeigen und Inhalte über verschiedene Websites hinweg basierend auf einem Profil und der Nutzungshistorie personalisiert auszuspielen Externe Inhalte: Zur Ergänzung unserer redaktionellen Texte nutzen wir in unseren Angeboten externe Inhalte und Dienste Dritter („Embeds“) wie interaktive Grafiken von denen wir diese externen Inhalten und Dienste beziehen Informationen auf Ihrem Gerät speichern oder abrufen und Ihre personenbezogenen Daten erheben und verarbeiten Für die Ihnen angezeigten Verarbeitungszwecke können Cookies Geräte-Kennungen oder andere Informationen auf Ihrem Gerät gespeichert oder abgerufen werden Anzeigen und Inhalte können basierend auf einem Profil personalisiert werden um Anzeigen und Inhalte besser zu personalisieren Die Performance von Anzeigen und Inhalten kann gemessen werden die die Anzeigen und Inhalte betrachtet haben Systeme und Software aufzubauen oder zu verbessern Hauptnavigation: Nutzen Sie die Tabulatortaste Schließen Sie Untermenüs mit der Escape-Taste Die Polizei hat in Fulda einen Mann erschossen der zuvor vor einer Bäckerei mehrere Menschen angegriffen und teilweise schwer verletzt haben soll Die Hintergründe des Angriffs seien noch unklar In Fulda schießen Polizisten einen jungen Mann nieder Der 19-Jährige soll zuvor an einer Bäckerei ausgerastet sein – mit Steinen und einem Schlagstock Die Verkäuferin schloss sich aus Angst ein Die Spuren der Randale sind deutlich: Zwei große Einschlagstellen von Steinwürfen sind zu sehen die Scheibe der Bäckerei in Fulda ist großflächig gerissen und gesplittert Auf der Straße sind Blutspuren mit Kunststofffolien abgedeckt an deren Ende die Polizei einen jungen Mann erschießt Er soll die alarmierten Beamten zuvor mit Steinwürfen und einem Schlagstock attackiert haben Aber viele Fragen bleiben noch unbeantwortet Am Mittag teilt die Staatsanwaltschaft die Identität des Mannes mit: Es handele sich um einen 19-jährigen Afghanen Er wohnte unweit der Bäckerei in einer Flüchtlingsunterkunft warum die von der Bäckerei zur Hilfe gerufenen Beamten ihre Waffen nutzten Das Hessische Landeskriminalamt (LKA) wurde eingeschaltet Das ist bei tödlichem Schusswaffengebrauch von Polizisten immer der Fall Der Mann soll laut den Ermittlern vor der Bäckerei randaliert haben Einen Lieferfahrer der Bäckerei soll er angegriffen und verletzt haben Der Angestellte musste ins Krankenhaus gebracht werden als die Beamten von dem jungen Mann angegriffen worden seien sagte am Vormittag am Tatort: „Unseren beiden Mitarbeitern geht es den Umständen entsprechend gut aber unser Fahrer musste ins Krankenhaus.“ Laut einer Statistik der Deutschen Hochschule der Polizei in Münster wurde im Jahr 2016 in 52 Fällen auf Menschen geschossen In Hessen schoss die Polizei im Jahr 2017 in fünf Fällen auf Menschen ob der Mann Alkohol getrunken oder Drogen genommen hatte die am frühen Morgen vor Ladenöffnung mit Arbeitsvorbereitungen beschäftigt war Deshalb habe sie vorsorglich die Eingangstür verriegelt Als der Warenzulieferer mit seinem Lastwagen vor der Filiale eintraf soll er von dem Mann angegriffen worden sein Der Fahrer konnte sich durch einen Seiteneingang in die Bäckerei flüchten Das Polizeipräsidium befindet sich in der Nähe der Bäckerei Mit Plastikfolie sind in der Flemingstraße Blutspuren abgedecktQuelle: dpa/Jörn Perske{"@context":"https://schema.org","@type":"ImageObject","contentUrl":"https://img.welt.de/img/vermischtes/mobile175439384/8436586607-coriginal-w2000/Angriff-vor-Baeckerei-in-Fulda-3.jpg","caption":"Mit Plastikfolie sind in der Flemingstraße Blutspuren abgedeckt","copyrightNotice":"dpa/Jörn Perske","creditText":"dpa/Jörn Perske","width":"2000"}Wahrscheinlich flüchtete der Angreifer Denn erst rund 150 Meter entfernt fielen mehrere Schüsse Der Tatort wurde am Freitag weiträumig von der Polizei abgesperrt wurde mit einem Zaun und Sichtschutzplanen vor neugierigen Blicken abgeschirmt Die WELT als ePaper: Die vollständige Ausgabe steht Ihnen bereits am Vorabend zur Verfügung – so sind Sie immer hochaktuell informiert Weitere Informationen https://epaper.welt.de Am Sonntagabend sind zwei Personen bei der Thurbrücke zwischen Brübach und Henau (SG) in einen Wasserfall geraten Die Verunglückten sind trotz intensiver Suche weiterhin vermisst Heute Montag sollen oberhalb des Wasserfalls Steinblöcke platziert werden die das Wasser kanalisieren und den Druck in jenem Bereich reduzieren Drucken Teilen (kapo/ahi/pw) Laut Kantonspolizei St.Gallen sind in Henau am Sonntagabend um 18.48 Uhr zwei Personen in die Thur gestürzt und mit der Strömung über den Wasserfall getrieben worden Gemäss ersten Erkenntnissen querten drei Personen oberhalb des Wasserfalls den Fluss stürzten in den Felseggfall und konnten sich dort offenbar nicht mehr befreien Bei den vermissten Personen handelt es sich um eine 26-jährige Schweizerin und einen 30-jährigen Schweizer Der Mann ist Polizist bei der Kantonspolizei St.Gallen Die Suche nach den vermissten Personen wurde am Sonntag um Mitternacht abgebrochen heute Montagmorgen jedoch wieder aufgenommen Laut dem Kommunikationschef der Kantonspolizei St.Gallen werden die Verunglückten nicht im Becken unterhalb des Wasserfalls vermutet Der Wasserdruck betrage dort rund 48 Tonnen pro Sekunde Um den Wasserdruck in jenem Bereich abzubauen sollen nun oberhalb des Wasserfalls Gesteinsbrocken ins Wasser gelegt werden Wie lange die Bergungsarbeiten andauern werden Dass die vermissten Personen noch lebend gefunden werden aber auch die Mitglieder des Korps der Kantonspolizei St.Gallen die am Sonntag einen Kollegen verloren haben Sands China has been given the green light to set up 150 new gaming tables in The Parisian Macao according to a statement made by the Secretary for Economy and Finance Regarding the expected end of the 26-month decline in gaming revenue Leong advised there is the need to wait for September’s gaming industry results “In fact there’s still some uncertainty and volatility gaming revenue in September has been lower than that of August,” he said You must be logged in to post a comment